New hope for bone loss after spinal injury: drug combo may protect knees
NCT ID NCT05101018
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This study compares two osteoporosis medications—romosozumab followed by denosumab versus denosumab alone—in 40 adults with a spinal cord injury that happened less than six months ago. The goal is to see which approach better maintains bone density around the knee over two years. Participants must be 18–55 years old and have no history of heart disease, stroke, or bone cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
James J. Peters VA Medical Center
The Bronx, New York, 10468, United States
-
Kessler Institute for Rehabilitation
West Orange, New Jersey, 07052, United States
Conditions
Explore the condition pages connected to this study.